Exogenous ANP Treatment Ameliorates Myocardial Insulin Resistance and Protects against Ischemia–Reperfusion Injury in Diet-Induced Obesity. This evidence concerns the gene NPPA and obesity due to melanocortin 4 receptor deficiency.